SPRYCEL 70mg. (Dasatinib Tablet) 70mg

SPRYCEL 70mg (dasatinib) is a prescription tablet used for certain blood cancers. It belongs to the tyrosine kinase inhibitor class, helping manage chronic myeloid leukemia and acute lymphoblastic leukemia. Store below 25°C to maintain potency.

Strength

70mg

Pack Size

60s

Storage

Below 25°C

Manufacturer / TM Owner

Bristol-Myers Squibb Holdings Pharma, Ltd.

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Dasatinib 70mg tablets are prescribed to treat specific types of leukemia, including chronic myeloid leukemia (CML) and Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL). It works by targeting abnormal proteins that drive cancer cell growth. Patients often ask, 'what is dasatinib 70mg used for' when discussing treatment options for blood cancers.

Side Effects

This medication helps reduce cancer cell proliferation by blocking signals that promote tumor growth. Many patients experience improved blood cell counts over time, though individual responses vary. Common effects include fatigue, nausea, or skin reactions as the body adjusts to treatment.

Precautions & Warnings

Keep dasatinib 70mg tablets in their original packaging and store below 25°C. Avoid exposure to moisture or direct sunlight. Regular medical check-ups are recommended to monitor blood counts and liver function during treatment.

Avoid Interactions

Dasatinib may interact with other medications, including certain antibiotics, antifungals, and heart medications. Grapefruit products can affect how dasatinib is processed in the body. Always inform your healthcare provider about all drugs you are taking before starting treatment.

Frequently Asked Questions

Dasatinib 70mg is prescribed to treat certain types of leukemia, including chronic myeloid leukemia (CML) and Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL).

Store dasatinib 70mg tablets below 25°C in their original packaging to protect from moisture and light.

Dasatinib can be taken with or without food, but it should be swallowed whole with water. Follow your doctor's instructions for timing.

Common effects may include fatigue, nausea, or skin reactions. Report persistent symptoms to your healthcare provider.

Yes, grapefruit products can interfere with how dasatinib is processed in the body. Avoid consuming grapefruit during treatment.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.